시장보고서
상품코드
1303129

유전자 패널 시장 - 세계 산업 규모, 점유율, 동향, 기회, 예측(2018-2028년)

Gene Panel Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented By Component, By Technique, By Design, By Application, By End User, By Region and Competition

발행일: | 리서치사: TechSci Research | 페이지 정보: 영문 117 Pages | 배송안내 : 2-3일 (영업일 기준)


※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 유전자 패널 시장은 예측 기간 동안 괄목할 만한 성장을 보일 것으로 예상됩니다.

이러한 현상은 다운증후군, 겸상적혈구증, 스테이삭스병과 같은 유전성 질환의 유병률이 증가하고 있기 때문인 것으로 보입니다. 대중의 의료 인식이 높아지고 조기 진단에 대한 수요가 증가함에 따라 많은 부부가 출산 계획 전이나 임신 중 유전자 검사를 선택해 예측 기간 동안 시장을 더욱 촉진할 것으로 보입니다. 저렴한 비용으로 신속하고 정확한 검사가 가능하기 때문에 유전자 패널의 적용이 증가하고 있으며, 이는 시장 성장을 촉진할 것으로 예상됩니다. 또한, 의료 인프라의 개선과 유전자 패널 관련 연구개발에 대한 투자 증가는 향후 몇 년 동안 시장 성장에 유리한 기회를 창출할 것으로 예상됩니다.

만성질환 발병률 증가

암, 선천성 질환, 심장마비, 관절염과 같은 만성 질환의 발병률 증가는 예측 기간 동안 유전자 패널 시장에서 성장할 것으로 예상됩니다. 유전자 돌연변이로 인한 질병의 증가는 유전자 패널 검사를 필요로 합니다. 유전자 패널 검사는 암과 관련된 여러 유전자의 변화를 동시에 분석하는 진단 기술입니다. 암 치료제 개발 및 출시를 위한 주요 기업들의 유전자 패널에 대한 높은 수요는 예측 기간 동안 유전자 패널 시장의 성장을 견인할 것으로 예상됩니다. Global cancer observatory에 따르면, 전 세계적으로 약 19,292,789건의 신규 암 사례가 보고되었으며, 이 중 여성은 9,227,484건, 남성은 약 10,065,305건의 신규 암 사례가 보고됐습니다. 암 유병률의 증가는 유전자 패널에 대한 수요를 증가시킬 것입니다. 높은 비용으로 인해 유전자 검사는 일반적으로 유전성 질환으로 인해 특정 유형의 암 발병 위험이 높은 환자에게만 시행됩니다. 여기에는 흡연, 불건강한 생활습관, 운동 부족, 음주와 같은 생활습관이 포함됩니다. 세계보건기구(WHO)에 따르면 선천성 기형으로 인해 생후 28일 이내에 사망하는 신생아는 전 세계적으로 매년 295,000명에 달합니다.

기술의 진보

임상 진단에서 개인 맞춤형 의약품과 함께 고급 의료 검사에 대한 수요 증가는 예측 기간 동안 시장 성장에 유리한 기회를 창출할 것입니다. 현재 유전자 질환은 노년층에서 많이 발생하여 유전자 패널 시장의 성장을 광범위하게 지원하고 있습니다. 많은 세계 기업들이 새롭고 진보된 유전자 패널 개발에 주력하고 있으며, 이는 향후 몇 년 동안 시장 성장을 더욱 촉진할 것으로 예상됩니다. 많은 민간 기업 및 정부 기관의 신기술 개발 노력과 투자 증가는 시장 성장을 촉진하는 주요 요인입니다. 미국에서는 매년 33명 중 1명꼴로 선천성 기형아가 태어나고 있으며, 이는 약 12만 명의 영아에 해당합니다.

사용 가능한 커스터마이징

TechSci Research는 주어진 시장 데이터를 사용하여 기업의 고유한 요구에 따라 맞춤화할 수 있습니다. 보고서에서 다음과 같은 커스터마이징이 가능합니다.

회사 소개

  • 추가 시장 진입 기업(최대 5개사)에 대한 심층 분석 및 프로파일링

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 유전자 패널 세계 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 컴포넌트별
    • 기술별
    • 디자인별
    • 최종사용자별
    • 지역별
    • 기업별
  • 시장 맵
    • 컴포넌트별
    • 기술별
    • 디자인별
    • 용도별
    • 최종사용자별
    • 지역별

제6장 북미의 유전자 패널 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 컴포넌트별
    • 기술별
    • 디자인별
    • 용도별
    • 최종사용자별
    • 국가별
  • 북미 국가별 분석
    • 미국
    • 캐나다
    • 멕시코

제7장 유럽의 유전자 패널 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 컴포넌트별
    • 기술별
    • 디자인별
    • 용도별
    • 최종사용자별
    • 국가별
  • 유럽 국가별 분석
    • 프랑스
    • 독일
    • 영국
    • 이탈리아
    • 스페인

제8장 아시아태평양의 유전자 패널 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 컴포넌트별
    • 기술별
    • 디자인별
    • 용도별
    • 최종사용자별
    • 국가별
  • 아시아태평양 국가별 분석
    • 중국
    • 인도
    • 일본
    • 한국
    • 호주

제9장 남미의 유전자 패널 시장 전망

  • 시장 규모와 예측
    • 금액 기준
  • 시장 점유율과 예측
    • 컴포넌트별
    • 기술별
    • 디자인별
    • 용도별
    • 최종사용자별
    • 국가별
  • 남미 : 국가별 분석
    • 브라질
    • 아르헨티나
    • 콜롬비아

제10장 중동 및 아프리카의 유전자 패널 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 컴포넌트별
    • 기술별
    • 디자인별
    • 용도별
    • 최종사용자별
    • 국가별
  • MEA : 국가별 분석
    • 남아프리카공화국
    • 사우디아라비아
    • 아랍에미리트

제11장 시장 역학

  • 성장 촉진요인
  • 과제

제12장 시장 동향과 발전

  • 최근의 동향
  • 인수합병
  • 제품 발표

제13장 경쟁 상황

  • Business Overview
  • Product Offerings
  • Recent Developments
  • Financials(As Reported)
  • Key Personnel
  • SWOT Analysis
    • Illumina, Inc.
    • Agilent Technologies, Inc.
    • Thermo Fischer Scientific, Inc.
    • QIAGEN NV
    • Eurofins Scientific SE
    • Foundation Medicine Inc.
    • Guardant Health, Inc.
    • Myriad Genetic Laboratories Inc.
    • Bio-Rad Laboratories, Inc.
    • F. Hoffmann-La Roche AG

제14장 전략적 제안

ksm 23.08.21

Global gene panel market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the growing prevalence of genetic disorders like Down syndrome, sickle cell disease, stay-Sachs disease, and others. Due to increasing healthcare awareness among the population and rising demand for early diagnosis, lots of couples opt for genetic testing before baby planning or during pregnancy, further boosting the market over the forecast period. Increasing application of gene panels owing to the low cost of the technique and fast and accurate testing is expected to propel market growth. Besides, improving healthcare infrastructure coupled with growing investments in research & development related to gene panels is further expected to create lucrative opportunities for market growth in the coming years.

Growing Incidence of Chronic Diseases

The rising incidence of chronic diseases such as cancer, congenital diseases, heart attack, and arthritis is expected to grow in the gene panel market during the forecast period. Increasing disorders because of genetic mutation demand gene panel testing. It is a diagnostic technique that analyses many genes for cancer-associated alterations at the same time. High demand for gene panels by the major key players to develop and launch cancer therapy is expected to growth of the gene panel market over the forecast period. According to the global cancer observatory, around 19,292,789 new cancer cases were reported worldwide. Out of these, 9,227,484 new cancer cases were reported in females, while the number of new cancer cases reported in men was around 10,065,305. The growing prevalence of cancer will increase the demand for gene panels. Given the high cost, genetic testing is usually only carried out on patients who are at a high risk of developing specific types of cancer because of their heredity disorder. This may include lifestyle factors such as smoking, leading an unhealthy lifestyle, reduced physical activity, and alcohol consumption. According to World Health Organization (WHO), around 295 000 newborns die within 28 days of birth every year worldwide due to congenital anomalies.

Technological Advancements

Increasing demand for advanced medical testing, along with personalized medicines in clinical diagnosis, will create lucrative opportunities for market growth in the forecast period. Currently, genetic disorders are common in the geriatric population, which supports the gene panel market growth extensively. Many global companies are focusing on developing new and advanced gene panels, which is further expected to propel market growth over the coming years. Increasing initiative and investment by many private and government organizations for developing new technology is a major factor that boosts market growth. Birth defects affect 1 in every 33 babies born in the United States each year, which translates into about 120,000 babies.

Market Segmentation

The global gene panel market can be segmented by component, technique, design, application, end-user, and by region. Based on components, the market can be divided into Test Kits and Testing Services. Based on technique, the market can be divided into Amplicon Based Approach and Hybridization Based Approach. Based on the design, the market can be divided into Predesigned Gene Panels and Customized Gene Panels. Based on Application, the market can be segmented into Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics, and Others. Based on end-user, the market can be differentiated into Academic & Research Institutes, Hospital & Diagnostic Laboratories, and Pharmaceutical & Biotechnology Companies. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among the different countries, the United States dominated the Global Gene Panel Market on account of the growing demand for gene panel techniques for rising cases of cancer across the globe. A little over 1.9 million new cancer cases are expected to be diagnosed in the United States in 2022, according to the 2022 Cancer Facts & Figures report from the American Cancer Society (ACS).

Market Players

Illumina, Inc., Agilent Technologies, Inc., Thermo Fischer Scientific, Inc., QIAGEN NV, Eurofins Scientific SE, Foundation Medicine Inc., Guardant Health, Inc., Myriad Genetic Laboratories Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG are some of the leading players operating in the Global Gene Panel Market.

Report Scope

In this report, global gene panel market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Gene Panel Market, By Component:

  • Test Kits
  • Testing Services

Gene Panel Market, By Technique:

  • Amplicon Based Approach
  • Hybridization Based Approach

Gene Panel Market, By Design:

  • Predesigned Gene Panel
  • Customized Gene Panel

Gene Panel Market, By Application:

  • Cancer Risk Assessment
  • Diagnosis of Congenital Diseases
  • Pharmacogenetics
  • Others

Gene Panel Market, By End User:

  • Academic & Research Institutes
  • Hospital & Diagnostic Laboratories
  • Pharmaceutical & Biotechnology Companies

Gene Panel Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Gene Panel Market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Gene Panel Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Component (Test Kits v/s Testing Services)
    • 5.2.2. By Technique (Amplicon Based Approach v/s Hybridization Based Approach)
    • 5.2.3. By Design (Predesigned Gene Panel v/s Customized Gene Panel)
    • 5.2.4. By Application (Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics, Others)
    • 5.2.5. By End User (Academic & Research Institutes, Hospital & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies)
    • 5.2.6. By Region
    • 5.2.7. By Company (2022)
  • 5.3. Market Map
    • 5.3.1. By Component
    • 5.3.2. By Technique
    • 5.3.3. By Design
    • 5.3.4. By Application
    • 5.3.5. By End User
    • 5.3.6. By Region

6. North America Gene Panel Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Component
    • 6.2.2. By Technique
    • 6.2.3. By Design
    • 6.2.4. By Application
    • 6.2.5. By End User
    • 6.2.6. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Gene Panel Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Component
        • 6.3.1.2.2. By Technique
        • 6.3.1.2.3. By Design
        • 6.3.1.2.4. By Application
        • 6.3.1.2.5. By End User
    • 6.3.2. Canada Gene Panel Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Component
        • 6.3.2.2.2. By Technique
        • 6.3.2.2.3. By Design
        • 6.3.2.2.4. By Application
        • 6.3.2.2.5. By End User
    • 6.3.3. Mexico Gene Panel Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Component
        • 6.3.3.2.2. By Technique
        • 6.3.3.2.3. By Design
        • 6.3.3.2.4. By Application
        • 6.3.3.2.5. By End User

7. Europe Gene Panel Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Component
    • 7.2.2. By Technique
    • 7.2.3. By Design
    • 7.2.4. By Application
    • 7.2.5. By End User
    • 7.2.6. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Gene Panel Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Component
        • 7.3.1.2.2. By Technique
        • 7.3.1.2.3. By Design
        • 7.3.1.2.4. By Application
        • 7.3.1.2.5. By End User
    • 7.3.2. Germany Gene Panel Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Component
        • 7.3.2.2.2. By Technique
        • 7.3.2.2.3. By Design
        • 7.3.2.2.4. By Application
        • 7.3.2.2.5. By End User
    • 7.3.3. United Kingdom Gene Panel Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Component
        • 7.3.3.2.2. By Technique
        • 7.3.3.2.3. By Design
        • 7.3.3.2.4. By Application
        • 7.3.3.2.5. By End User
    • 7.3.4. Italy Gene Panel Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Component
        • 7.3.4.2.2. By Technique
        • 7.3.4.2.3. By Design
        • 7.3.4.2.4. By Application
        • 7.3.4.2.5. By End User
    • 7.3.5. Spain Gene Panel Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Component
        • 7.3.5.2.2. By Technique
        • 7.3.5.2.3. By Design
        • 7.3.5.2.4. By Application
        • 7.3.5.2.5. By End User

8. Asia-Pacific Gene Panel Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Component
    • 8.2.2. By Technique
    • 8.2.3. By Design
    • 8.2.4. By Application
    • 8.2.5. By End User
    • 8.2.6. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Gene Panel Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Component
        • 8.3.1.2.2. By Technique
        • 8.3.1.2.3. By Design
        • 8.3.1.2.4. By Application
        • 8.3.1.2.5. By End User
    • 8.3.2. India Gene Panel Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Component
        • 8.3.2.2.2. By Technique
        • 8.3.2.2.3. By Design
        • 8.3.2.2.4. By Application
        • 8.3.2.2.5. By End User
    • 8.3.3. Japan Gene Panel Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Component
        • 8.3.3.2.2. By Technique
        • 8.3.3.2.3. By Design
        • 8.3.3.2.4. By Application
        • 8.3.3.2.5. By End User
    • 8.3.4. South Korea Gene Panel Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Component
        • 8.3.4.2.2. By Technique
        • 8.3.4.2.3. By Design
        • 8.3.4.2.4. By Application
        • 8.3.4.2.5. By End User
    • 8.3.5. Australia Gene Panel Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Component
        • 8.3.5.2.2. By Technique
        • 8.3.5.2.3. By Design
        • 8.3.5.2.4. By Application
        • 8.3.5.2.5. By End User

9. South America Gene Panel Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Component
    • 9.2.2. By Technique
    • 9.2.3. By Design
    • 9.2.4. By Application
    • 9.2.5. By End User
    • 9.2.6. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Gene Panel Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Component
        • 9.3.1.2.2. By Technique
        • 9.3.1.2.3. By Design
        • 9.3.1.2.4. By Application
        • 9.3.1.2.5. By End User
    • 9.3.2. Argentina Gene Panel Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Component
        • 9.3.2.2.2. By Technique
        • 9.3.2.2.3. By Design
        • 9.3.2.2.4. By Application
        • 9.3.2.2.5. By End User
    • 9.3.3. Colombia Gene Panel Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Component
        • 9.3.3.2.2. By Technique
        • 9.3.3.2.3. By Design
        • 9.3.3.2.4. By Application
        • 9.3.3.2.5. By End User

10. Middle East and Africa Gene Panel Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Component
    • 10.2.2. By Technique
    • 10.2.3. By Design
    • 10.2.4. By Application
    • 10.2.5. By End User
    • 10.2.6. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Gene Panel Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Component
        • 10.3.1.2.2. By Technique
        • 10.3.1.2.3. By Design
        • 10.3.1.2.4. By Application
        • 10.3.1.2.5. By End User
    • 10.3.2. Saudi Arabia Gene Panel Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Component
        • 10.3.2.2.2. By Technique
        • 10.3.2.2.3. By Design
        • 10.3.2.2.4. By Application
        • 10.3.2.2.5. By End User
    • 10.3.3. UAE Gene Panel Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Component
        • 10.3.3.2.2. By Technique
        • 10.3.3.2.3. By Design
        • 10.3.3.2.4. By Application
        • 10.3.3.2.5. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Competitive Landscape

  • 13.1. Business Overview
  • 13.2. Product Offerings
  • 13.3. Recent Developments
  • 13.4. Financials (As Reported)
  • 13.5. Key Personnel
  • 13.6. SWOT Analysis
    • 13.6.1. Illumina, Inc.
    • 13.6.2. Agilent Technologies, Inc.
    • 13.6.3. Thermo Fischer Scientific, Inc.
    • 13.6.4. QIAGEN NV
    • 13.6.5. Eurofins Scientific SE
    • 13.6.6. Foundation Medicine Inc.
    • 13.6.7. Guardant Health, Inc.
    • 13.6.8. Myriad Genetic Laboratories Inc.
    • 13.6.9. Bio-Rad Laboratories, Inc.
    • 13.6.10. F. Hoffmann-La Roche AG

14. Strategic Recommendations

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제